Comparing Two Tests for Cancer Cell Response to Drugs
Author Information
Author(s): J.A. Hanson, E.A. Bean, A.M. Coombs, J.L. Moore
Primary Institution: Department of Radiation Sciences, Velindre Hospital, Cardiff and Department of Pharmacy, The University, Bath, UK
Hypothesis
Can a short-term labelling assay provide a reliable alternative to the soft agar clonogenic assay for evaluating human tumor responses to chemotherapy?
Conclusion
The short-term labelling assay shows good agreement with the clonogenic survival assay for measuring cell response to chemotherapy in human tumor xenografts.
Supporting Evidence
- The short-term assay does not require a pure single cell suspension, making it easier to use.
- Results from the short-term assay can be obtained within a week, compared to 3 to 6 weeks for the clonogenic assay.
- The study found good correlations between the two assays for the agents tested.
- Initial results indicate that the short-term assay may be useful for individual patient chemosensitivity testing.
Takeaway
Scientists are trying to find a faster way to test how cancer cells respond to drugs, and they think a new method might work just as well as the old one.
Methodology
The study compared a soft agar clonogenic assay with a short-term labelling assay using human tumor xenograft cells exposed to drugs and radiation.
Limitations
The study is limited by the low cloning efficiency of the cells used, which restricts the range of measurable cell kill.
Want to read the original?
Access the complete publication on the publisher's website